If the first nine months of 2006 are any indication, a healthy amount of venture capital dollars continue to be applied in the biotechnology space, noted Michael Rosen, our well-traveled columnist. However, in this edition of Yer Biotech Blues, he points out the minimal impact...
Bringing entrepreneurship to economically disadvantaged areas is one of the goals of an entrepreneurship initiative established by the Kauffman Foundation, and the University of Wisconsin-Madison is one of eight campuses selected to participate in the program. To help make it happen, the university has received...
Madison's Mirus Bio Corp. has been granted a patent on a new and more rapid method of delivering nucleic acids for the study of gene function. The company, which is pursuing strategic alliances to apply the technology, said it allows researchers to regulate gene expression...
With the goal of connecting institutional investors to Wisconsin companies, the State Department of Financial Institutions and the Department of Commerce are collaborating on a proposal to create a Wisconsin Venture Center. The center is based on an Ohio collaborative model called BioEnterprise....
Addressing the problem of antibiotic resistance has helped Madison-based ConjuGon land $3.3 million in capital from Rosetta Partners and Wisconsin Investment Partners. ConjuGon will use the money not only to develop its core antibacterial technology, but to prepare for clinical trials of its treatment for...
For those wondering what Beth Donley's next move would be, it's an entrepreneurial step. Donley, who surprised many in October by resigning as executive director of WiCell, is teaming with University of Wisconsin-Madison scientist Gabriela Cezar to launch a new stem cell company....
The Morgridge Institute for Research, a collaborative research institute funded by John Morgridge, chairman of the board of Cisco Systems, is looking for candidates to fill the role of executive director....
You'll have to excuse drug companies if they feel caught in a vice between those who want to make "big pharma" a political bogeyman and consumers who want too much, too soon. In the latest Inside Wisconsin, Tom Still points to a Tufts University study...
Image guidance and adaptive treatment has placed TomoTherapy among the top radiation therapy providers. As CEO Fred Robertson explains, its ability to remain there is dependent on a novel platform technology that will enable future software innovation. ...
Adult stem cells continue to provide applications in the scientific and medical realms, as demonstrated by the findings of Medical College of Wisconsin researcher Maya Sieber-Blum. Sieber-Blum hopes to commercialize her discovery of an adult stem cell that is found in hair follicles....